Day: May 15, 2024

Earnings Call Webcast to Discuss First Quarter Financial Results Scheduled to Post to Corporate Website on Friday, May 17, 2024 NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the First Quarter ended March 31, 2024. First Quarter 2024 Summary Results During the First Quarter 2024, the disrupted movie release schedule caused by the 2023 Hollywood Strikes continued to negatively impact our financial results. Despite these revenue setbacks, our global operations teams managed our cinema expenses to reduce our overall First Quarter 2024 operating loss. As our cinema business endured these temporary...

PLAINVIEW, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — Vaso Corporation (“Vaso”) (OTCQX: VASO) today reported its operating results for the three months ended March 31, 2024. “Total revenue for the first quarter of 2024 was $18.7 million, a decrease of $0.3 million or 1.6% when compared to the same quarter last year, mainly due to lower sales in the equipment segment.  Quarterly gross profit was $10.9 million, a decrease of $0.6 million or 5.6% year-over-year, as a result of lower revenue and lower gross margin,” stated Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation.  “We have also recorded a net loss of approximately $1.2 million for the quarter, as we usually incur losses historically in the early quarters of the year due to the cyclic nature of our businesses.”  “Our operating cashflow in the first quarter improved...

Highlights     (in million USD, except EPS)   Q1 2024 Q1 2023 Net Revenues   $38.3 $18.0   Net income / (loss)   $10.2 ($4.2)   Adjusted net income1 / (loss)   $11.6 ($0.4)   EBITDA1   $21.6 $8.2   Adjusted EBITDA1   $23.2 $3.9           Earnings / (loss) per share Basic & Diluted   $0.50 ($0.23)   Adjusted earnings / (loss) per share Basic1   $0.58 ($0.02)   Adjusted earnings / (loss) per share Diluted1   $0.57 ($0.02)   Other Highlights and Developments: Record first quarter net income of $10.2 million Cash dividends of $0.15 per share consisting of a quarterly cash dividend of $0.025 per share for Q1 2024 and a special cash dividend of $0.125 per share Total cash dividends of $1.60 per share, or $29.6 million, declared since March 2022 Acquisition of two Japanese Capesize vessels, built in 2013 and 2012,...

CHICAGO, May 15, 2024 (GLOBE NEWSWIRE) — Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse individuals, today announced its financial results for the quarter ended March 31, 2024. “Our first quarter showed a mixed bag within our revenue streams. Demand for direct enterprise sales was light at the beginning of the quarter, however we recorded the best quarterly renewal percentage in the Company’s history. We continue to focus on strategic targeting of industries and business that we feel are in need of our services. RemoteMore was behind budget for the quarter as demand was slow in the period, but is in conversation with numerous potential...

GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the first quarter of 2024. Cary Claiborne, President and Chief Executive Officer of Adial, stated, “We are making steady progress as it relates to AD04. We have initiated new activities related to our clinical development plan after incorporating favorable feedback received from the FDA last year. We anticipate conducting two parallel Phase 3 clinical trials of AD04 to support potential approval in the shortest timeframe possible while minimizing risk. To support our efforts, we formally hired Tony...

– Q1 Revenue Increased 20% Sequentially to $11.4 Million –   – Commenced Trading on Nasdaq on May 2, 2024, Marking Key Corporate Milestone –   IRVING, Texas, May 15, 2024 (GLOBE NEWSWIRE) —  Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating results for the first quarter ended March 31, 2024. “We carried our momentum into the first quarter of 2024 and continued to address strong consumer demand for freeze dried candy,” said Claudia Goldfarb, CEO of Sow Good. “Our first quarter revenue of $11.4 million represents a 20% sequential increase relative to the fourth quarter of 2023 and a significant year-over-year expansion. During the quarter, we made meaningful strides in building both our production capacity...

– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today reported financial results and recent corporate highlights for the first quarter ended March 31, 2024. “The first quarter was incredibly productive for Avenue, as we’ve successfully executed on key milestones across our pipeline of CNS treatments,” said Alexandra MacLean, M.D., Chief Executive Officer of Avenue. “We made significant strides advancing our lead clinical program, AJ201, in spinal and bulbar muscular atrophy (“SBMA”), also known as Kennedy’s Disease and look forward...